Clozapine, a new antipsychotic drug without extrapyramidal side effects and with strong sedating potency, can produce acute symptoms of central anticholinergic toxicity. The authors report that physostigmine, a reversible anticholinesterase agent, which can pass the blood-brain barrier, was effective in reversing the clozapine-induced brain syndrome in two patients. Physostigmine also reduced one patient's tachycardia.
No takes yet. Share an insight, caveat, or question.
Schuster et al. (1977) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: